The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2025

Filed:

Oct. 29, 2020
Applicant:

Daegu-gyeongbuk Medical Innovation Foundation, Daegu, KR;

Inventors:

Ji-Hoon Yu, Daegu, KR;

Chun Young Im, Daegu, KR;

So Young Kim, Daegu, KR;

Ye Ri Han, Daegu, KR;

Doohyun Lee, Daegu, KR;

Hui-Jeon Jeon, Daegu, KR;

Sang-Hyun Min, Daegu, KR;

Bae Jun Oh, Daegu, KR;

Sang-Wook Park, Daegu, KR;

Dong-Kyu Choi, Daegu, KR;

Young-Kyu Kim, Daegu, KR;

Sung Hwan Kim, Daegu, KR;

Yuri Lee, Daegu, KR;

Seungyeon Lee, Daegu, KR;

Nam Hui Kim, Daegu, KR;

Sang Bum Kim, Daegu, KR;

Ju-Sik Min, Daegu, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/55 (2017.01); A61K 47/54 (2017.01); A61P 35/00 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
A61K 47/55 (2017.08); A61K 47/545 (2017.08); A61P 35/00 (2018.01); C07D 405/14 (2013.01);
Abstract

The present invention relates to a compound comprising an EZH2 inhibitor and an E3 ligase binder, and a pharmaceutical composition for preventing or treating EZH2-associated disease and a pharmaceutical composition for selective protein degradation containing the same as an active ingredient. Since the compound of the present invention can selectively degrade EZH2, it can be effectively used for the treatment of EZH2-related diseases and cancers, particularly, cancers in which EZH2 is overexpressed, and can be usefully used for the selective degradation of EZH2.


Find Patent Forward Citations

Yu, Ji-Hoon. (2025). Compound comprising ezh2 inhibitor and e3 ligase binder and pharmaceutical composition for preventing or treating ezh2-associated disease comprising same as active ingredient (U.S. Patent No. 12502434). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12502434

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…